Table 1

Description of the instruments used for the evaluation of all patients

InstrumentDescriptionDomains/subscalesScore
MoCA31 35Test for the rapid screening of mild cognitive impairment—an intermediate clinical state between normal cognitive ageing and dementia.Attention and concentration; executive functions; memory; language; visuoconstructional skills; calculations; orientation.Range: 0–30
Higher scores represent better cognitive performance.
Cube Test33A two-task cognitive screening tool that consists in completing a 3D cube from six pieces (task 1) and remembering the position of the six pieces on a grid with 25 squares measuring eight by eight centimeters from a previously shown scheme (task 2).Visuoconstructional skills; executive function; processing speed; delayed memory.Time to construct the first vertex and to complete cube and the number of pieces correctly assembled in up to 6 min (task 1); number of pieces correctly positioned on the grid (task 2).
Brain on Track34A self-administered computerised test intended for longitudinal cognitive testing that includes eight subtests.Attention; memory; executive functions; language; calculation; constructive ability; visuospatial processing.Range: virtually unlimited (maximum number of correct answers in a fixed time)
Higher scores represent better cognitive performance.
Scores falling below an expected performance threshold for each age/education group; a pattern of decline in individual performance.
HADS21 22Scale with 14 questions assessing anxiety and emotional distress among patients during the previous week.Depression; anxiety.Range (for each subscale): 0 to 21
Scores greater than or equal to 11 represent a case of anxiety or depression, as applicable.
PSQI23 24Index with 18 questions assessing sleep quality and disturbances during the previous month.Subjective sleep quality; sleep latency; duration of sleep; habitual sleep efficiency; sleep disorders; use of medications for sleep; daytime dysfunction.Range: 0–21
Scores greater than five indicate poor sleep quality.
QLQ-C3025 26Scale with 30 questions assessing quality of life in patients with cancer during the previous week.Global health status.Range (scales and single-item): 0–100
Functional scales: physical functioning; role functioning; emotional functioning; cognitive functioning; social functioning.Higher scores for the global health status and for a functional scale represent a healthy level of quality of life and functioning, respectively.
Symptom scales/items: fatigue; nausea and vomiting; pain; dyspnoea; insomnia; appetite loss; constipation; diarrhoea; financial difficulties.Higher scores for a symptom scale/item represents a higher level of symptomatology/ problems.
QLQ-PR2527Specific Prostate Cancer Scale with 25 questions assessing quality of life in patients with prostate cancer during the previous week and the last 4 weeks.Functional scales: sexual activity; sexual functioning.Range (scales and single-item): 0 to 100
Symptom scales: urinary symptoms; bowel symptoms; hormonal treatment-related symptoms; incontinence aid.Higher scores for a function scale/item reflect a healthy level of functioning.
Higher scores for a symptom scale/item reflect a higher level of symptomatology/problems.
EQ-5D-5L28A measure of health-related quality of life with five questions and a Visual Analogue Scale.Mobility, self-care, usual activities, pain/discomfort; anxiety/depression and a visual analogue scale.A total of 3125 possible health states are defined to describe the patient’s health state. Each state is referred to in terms of a 5-digit code.
Vertical Visual Analogue Scale
Range: 0–100
Higher scores reflect ‘The best health you can imagine’ and lower scores reflect ‘The worst health you can imagine’.
METER29 30A measure of health literary including 40 words and 30 non-words.40 words and 30 non-words.Range: 0–40 and 0–30
Adequate health literacy is defined as scoring at least 35/40 in words and 18/30 in non-words.
  • 3D, three dimensions; EQ-5D-5L, Measure of health-related quality of life of the EuroQol Group; HADS, Hospital Anxiety and Depression Scale; METER, Medical Term Recognition Test; MoCA, Montreal Cognitive Assessment; PSQI, Pittsburgh Sleep Quality Index; QLQ-C30, Quality of Life Questionnaire of the European Organisation for Research and Treatment of Cancer; QLQ-PR25, Prostate cancer-specific module of the Quality of Life Questionnaire of the European Organisation for Research and Treatment of Cancer.